Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             40 results found
no title author magazine year volume issue page(s) type
1 A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi Kothari, Sudeep
 2013
 31 42 p. 4714-4719
6 p.
 article
2 Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy Abzug, Mark J.
 2013
 31 42 p. 4782-4790
9 p.
 article
3 Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein Céspedes, Nora
 2013
 31 42 p. 4923-4930
8 p.
 article
4 An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection Cayabyab, Mark J.
 2013
 31 42 p. 4834-4840
7 p.
 article
5 A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA Frey, Sharon E.
 2013
 31 42 p. 4874-4880
7 p.
 article
6 Associations between health communication behaviors, neighborhood social capital, vaccine knowledge, and parents’ H1N1 vaccination of their children Jung, Minsoo
 2013
 31 42 p. 4860-4866
7 p.
 article
7 Attenuation of Theileria lestoquardi infected cells and immunization of sheep against malignant ovine theileriosis Ahmed, Bukhari M.
 2013
 31 42 p. 4775-4781
7 p.
 article
8 Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines Tontini, M.
 2013
 31 42 p. 4827-4833
7 p.
 article
9 Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials Arbues, Ainhoa
 2013
 31 42 p. 4867-4873
7 p.
 article
10 Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate Lal, Manjari
 2013
 31 42 p. 4759-4764
6 p.
 article
11 Editorial Board/Aims and Scope 2013
 31 42 p. CO2-
1 p.
 article
12 Effect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetes Weinberg, Adriana
 2013
 31 42 p. 4791-4794
4 p.
 article
13 Epitope engineering and molecular metrics of immunogenicity: A computational approach to VLP-based vaccine design Joshi, Harshad
 2013
 31 42 p. 4841-4847
7 p.
 article
14 EuSANH workshop “Reasons behind the differences in national vaccination schedules for under-five”, European Public Health pre-conference workshop, Malta, 8 November 2012 Theeten, H.
 2013
 31 42 p. 4694-4696
3 p.
 article
15 Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16) Dorneles, Elaine Maria Seles
 2013
 31 42 p. 4856-4859
4 p.
 article
16 H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus Rudenko, Larisa
 2013
 31 42 p. 4702-4705
4 p.
 article
17 Hsp70 vaccination-induced primary immune responses in efferent lymph of the draining lymph node Vrieling, Manouk
 2013
 31 42 p. 4720-4727
8 p.
 article
18 Human papillomavirus vaccine communication: Perspectives of 11–12 year-old girls, mothers, and clinicians Mullins, Tanya L. Kowalczyk
 2013
 31 42 p. 4894-4901
8 p.
 article
19 Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule Rodgers, Gail L.
 2013
 31 42 p. 4765-4774
10 p.
 article
20 Immunization guidelines in the United States: New vaccines and new recommendations for children, adolescents, and adults Poland, Gregory A.
 2013
 31 42 p. 4689-4693
5 p.
 article
21 Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques DiStefano, Daniel
 2013
 31 42 p. 4888-4893
6 p.
 article
22 Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments Gomila, Raúl C.
 2013
 31 42 p. 4736-4743
8 p.
 article
23 In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations Scherließ, Regina
 2013
 31 42 p. 4812-4819
8 p.
 article
24 Is there a lack of information on HPV vaccination given by health professionals to young women? La Torre, G.
 2013
 31 42 p. 4710-4713
4 p.
 article
25 Lesser protein degradation machinery correlates with higher BM86 tick vaccine efficacy in Rhipicephalus annulatus when compared to Rhipicephalus microplus Popara, Marina
 2013
 31 42 p. 4728-4735
8 p.
 article
26 Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens Iankov, Ianko D.
 2013
 31 42 p. 4795-4801
7 p.
 article
27 Neutralizing antibodies associated with exposure factors to Orthopoxvirus in laboratory workers Costa, Galileu Barbosa
 2013
 31 42 p. 4706-4709
4 p.
 article
28 Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010 Khetsuriani, Nino
 2013
 31 42 p. 4911-4916
6 p.
 article
29 Public finance of rotavirus vaccination in India and Ethiopia: An extended cost-effectiveness analysis Verguet, Stéphane
 2013
 31 42 p. 4902-4910
9 p.
 article
30 Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model Shafer, Leigh Anne
 2013
 31 42 p. 4848-4855
8 p.
 article
31 Risk of invasive pneumococcal disease in children and adults with asthma: A systematic review Boikos, Constantina
 2013
 31 42 p. 4820-4826
7 p.
 article
32 Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: Nationwide population-based survey, 2010 Khetsuriani, Nino
 2013
 31 42 p. 4917-4922
6 p.
 article
33 Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations Hackel, M.
 2013
 31 42 p. 4881-4887
7 p.
 article
34 SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12 Lindsay, Ross W.
 2013
 31 42 p. 4749-4758
10 p.
 article
35 The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has established a new vaccine study group (EVASG) 2013
 31 42 p. 4931-
1 p.
 article
36 The History of Vaccines.org publishes a book Plotkin, Stanley A.
 2013
 31 42 p. 4697-
1 p.
 article
37 The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates Waye, Arianna
 2013
 31 42 p. 4744-4748
5 p.
 article
38 Towards rationale vaccine policy: A case against inclusion of rabies vaccine into routine national immunization programme in India Patil, Rajan R.
 2013
 31 42 p. 4698-
1 p.
 article
39 Use of alternative childhood immunization schedules in King County, Washington, USA Opel, Douglas J.
 2013
 31 42 p. 4699-4701
3 p.
 article
40 Vaccination with Flt3L-induced CD8α+ dendritic cells prevents CD4+ T helper cell-mediated experimental autoimmune myocarditis Valaperti, Alan
 2013
 31 42 p. 4802-4811
10 p.
 article
                             40 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands